Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06908057 · ClinicalTrials.gov registry record
Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)
A clinical trial of Type 1 Diabetes and Celiac Disease, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06908057 is a study of Type 1 Diabetes and Celiac Disease that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 200 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06908057, a study of Type 1 Diabetes and Celiac Disease, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.
Conditions Studied
Interventions
- OTHER Blood Draw
Study Locations (1)
Florida
- AdventHealth Translational Research Institute - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06908057
The ClinicalTrials.gov registry entry for NCT06908057 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (76% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.
NCT06908057 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06908057 about?
NCT06908057 is a clinical study titled "Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)". The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.
What is the current status of trial NCT06908057?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-03-11. Estimated completion is 2026-06.
What conditions does trial NCT06908057 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Celiac Disease.
What interventions are being tested in trial NCT06908057?
The interventions under investigation include: Blood Draw (OTHER).
Who is sponsoring clinical trial NCT06908057?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06908057 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.